Indonesia vs Uganda: The number of people with susceptibility test result for rifampicin
Indonesia
72.55
in 2021
Uganda
74.76
in 2021
Indonesia rank
102nd
Uganda rank
101st
The number of people with susceptibility test result for rifampicin over time
- Indonesia
- Uganda
How they compare
Uganda currently reports 74.76 against 72.55 in Indonesia, a difference of 2.21.
Across all 5 years both countries report, Uganda has been ahead every year.
Indonesia ranks 102nd and Uganda ranks 101st of 146 countries.
Uganda has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Indonesia | Uganda | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 30.84 | 82.7 | 51.86 | Uganda |
| 2020s | 65.06 | 68.69 | 3.62 | Uganda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Indonesia or Uganda?
- Uganda, at 74.76 against 72.55 in Indonesia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Indonesia and Uganda?
- 2.21, with Uganda ahead.
- How many years of comparable data are there for Indonesia and Uganda?
- 5 years are reported by both, from 2017 to 2021.
- How do Indonesia and Uganda rank globally for the number of people with susceptibility test result for rifampicin?
- Indonesia ranks 102nd and Uganda ranks 101st of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.